(Press-News.org) CLEVELAND -- New research published in the March 15 issue of the New England Journal of Medicine (embargoed 5 pm ET March 14) identifies gene mutations associated with improved overall survival with higher doses of chemotherapy for patients with acute myeloid leukemia (AML).
According to one of the authors, Hillard M. Lazarus, MD, Director of Novel Cell Therapy at Seidman Cancer Center at University Hospitals Case Medical Center and Professor of Medicine at Case Western Reserve University School of Medicine, the findings explain why some AML patients are more likely to benefit from higher does of the chemotherapy drug daunorubicin.
"This is yet another advance in the era of 'individualizing' a patient's care," said Dr. Lazarus. "These significant findings will provide an important new tool to predict patients' response to cancer-fighting therapies and will help physicians avoid over-treating some patients and under-treating others."
The new study performed an analysis of mutations in 18 genes in 398 patients younger than 60 years of age with AML who were randomly assigned to receive therapy with high-dose or standard dose daunorubicin. Researchers validated their prognostic findings in an independent set of 104 patients.
The researchers found that mutations in two genes (DNMT3A and NPM1) and translocations (movement of part of one gene to another gene, the MLL gene) were associated with improved patient outcomes with the higher doses of daunorubicin chemotherapy in AML patients.
"Information of this type could be used by a clinician for treatment planning at diagnosis and the start of therapy," said Dr. Lazarus. "That is, if the patient has the mutation in question, the clinician can go ahead and give the higher chemotherapy dose. If the patient does not have the mutation, a higher dose may not be of benefit."
The multi-site study is an analysis of genetic factors from patients who participated in a landmark 2009 study which changed the routine treatment practice for AML. That study, also published in the New England Journal of Medicine, demonstrated for the first time that a more intense initial regimen using higher doses of daunorubicin significantly improved remission rate (70.6% vs. 57.3% with a standard dose) and improved overall survival (median, 23.7 vs. 15.7 months). More patients achieved remission with only one cycle of therapy, rather than two cycles, more patients proceeded to transplant, and overall outcome was significantly improved.
Dr. Lazarus said, "These findings show how genetic information can be used to 'tailor' therapy for patients. Now the challenge before us is to find a way to provide this genetic information in a timely and affordable way to influence treatment decisions for patients. Hopefully we can answer additional important questions such as these by continuing to enroll patients onto clinical trials"
###The study was led by researchers from Memorial Sloan-Kettering Cancer Center. Dr. Lazarus' work was supported by Eastern Cooperative Oncology Group and National Cancer Institute grants to Case Western Reserve University School of Medicine.
About University Hospitals
University Hospitals serves the needs of patients through an integrated network of hospitals, outpatient centers and primary care physicians. At the core of our health system is University Hospitals Case Medical Center. The primary affiliate of Case Western Reserve University School of Medicine, University Hospitals Case Medical Center is home to some of the most prestigious clinical and research centers of excellence in the nation and the world, including cancer, pediatrics, women's health, orthopedics and spine, radiology and radiation oncology, neurosurgery and neuroscience, cardiology and cardiovascular surgery, organ transplantation and human genetics. Its main campus includes the internationally celebrated UH Rainbow Babies & Children's Hospital, ranked among the top children's hospitals in the nation; UH MacDonald Women's Hospital, Ohio's only hospital for women; and UH Seidman Cancer Center, part of the NCI-designated Case Comprehensive Cancer Center at Case Western Reserve University. For more information, go to www.uhhospitals.org
Study finds genes improving survival with higher chemo doses in leukemia
University Hospitals Case Medical Center cancer researcher helps advance 'individualized' patient care with the find
2012-03-15
ELSE PRESS RELEASES FROM THIS DATE:
New study lowers estimate of ancient sea-level rise
2012-03-15
The seas are creeping higher as the planet warms. But how high will they go? Projections for the year 2100 range from inches to several feet, or more. The sub-tropical islands of Bermuda and the Bahamas contain important sites where researchers have gone looking for answers; by pinpointing where shorelines stood on cliffs and reefs there during an extremely warm period 400,000 years ago, they hope to narrow the range of global sea-level projections for the future.
After correcting for what they say were the sinking of the islands at that time, a new study in the journal ...
Study: US tobacco-control efforts prevented nearly 800,000 cancer deaths between 1975 and 2000
2012-03-15
SEATTLE – Declines in cigarette smoking among Americans since the mid-1950s – particularly since tobacco-control policies and interventions were implemented after the U.S. Surgeon General's Report on Smoking and Health was released in 1964 – prevented nearly 800,000 lung cancer deaths between 1975 and 2000, according to a study led by researchers at Fred Hutchinson Cancer Research Center.
Results of the National Cancer Institute-funded study, conducted by a consortium of six research groups in the U.S. and the Netherlands, are published online in the Journal of the National ...
Study Shows Chemotherapy Combination Effective for Mesothelioma Patients
2012-03-15
Individuals suffering from Mesothelioma know all too well the aggressive nature of the disease. Fortunately, a new clinical trial shows positive results for some patients taking a particular type of chemotherapy combination.
What is Mesothelioma?
Mesothelioma is a rare type of cancer that afflicts the meothelium or thin membrane that covers a person's lungs, heart and other vital organs. The cancer is most commonly caused by the inhalation of microscopic asbestos fibers.
Asbestos fibers were first used by U.S. manufacturers and builders in the late 19th century ...
Mystery human fossils put spotlight on China
2012-03-15
Fossils from two caves in south-west China have revealed a previously unknown Stone Age people and give a rare glimpse of a recent stage of human evolution with startling implications for the early peopling of Asia.
The fossils are of a people with a highly unusual mix of archaic and modern anatomical features and are the youngest of their kind ever found in mainland East Asia.
Dated to just 14,500 to 11,500 years old, these people would have shared the landscape with modern-looking people at a time when China's earliest farming cultures were beginning, says an international ...
Reducing drug overdose for ex-prisoners -- the view from outside the prison gates
2012-03-15
Prison inmates frequently have a strong history of drug use and misuse, especially during the time prior to incarceration, and drugs often are the driving force behind the offense itself. New research, published in BioMed Central's newly launched open access journal Addiction Science & Clinical Practice, shows that ex-offenders struggle to remain drug free after release from prison and identifies factors that can help them succeed. Interviews with former inmates show that they themselves recognize that returning to former living environments (former friends and an easy ...
Social networking shortcut to finding medical experts
2012-03-15
It can be difficult for someone outside of a specialist field to identify subject experts and the ever increasing amount of available data can be bewildering. New research, published in BioMed Central's open access journal, Journal of Biomedical Semantics, describes a method of social network analysis, similar to finding friends on Facebook, able to sift through scientific literature and news articles to identify opinion leaders and media experts.
Pharmaceutical companies and public health programs rely on opinion leaders to clarify and condense research into a format ...
'Personalized immune' mouse offers new tool for studying autoimmune diseases
2012-03-15
New York, NY (March 14, 2012) — Columbia University Medical Center (CUMC) scientists have developed a way to recreate an individual's immune system in a mouse. The "personalized immune mouse" offers researchers an unprecedented tool for individualized analysis of abnormalities that contribute to type 1 diabetes and other autoimmune diseases, starting at the onset of disease. The findings were published today in the online edition of Science Translational Medicine.
The mouse model could also have clinical applications, such as predicting how a particular patient might ...
Study finds expensive procedure no more effective than medical therapy to prevent strokes
2012-03-15
CLEVELAND -- A catheter procedure that closes a hole in patients' hearts was no more effective than medical therapy in preventing recurrent strokes, according to a new study published in the March 15 issue of the New England Journal of Medicine.
In the CLOSURE I trial, clinical researchers compared a catheter procedure plus medical therapy with medications alone to prevent new strokes or transient ischemic attacks (TIAs) in patients between 18 and 60 years old with an unexplained ("cryptogenic") stroke or TIA and a patent foremen ovale (PFO) – a hole between the heart's ...
Researchers identify unexpected player in intestinal immunity
2012-03-15
VIDEO:
Using two-photon imaging, the researchers were able to see dendritic cells, shown in green, in the intestine of a living mouse.
Click here for more information.
With every meal, immune cells in the intestine stand like sentries at a citadel, turning away harmful bacteria but allowing vitamins and nutrients to pass.
Now, researchers at Washington University School of Medicine in St. Louis have identified the cells that chaperone food antigens, or proteins, in the ...
Mortgage Settlement Allotment to Struggling WI Homeowners: Too Little too Late?
2012-03-15
Of the $25 billion federal settlement funds for mortgage foreclosure abuses, Wisconsin will receive $140 million. The settlement money is being paid by J.P. Morgan Chase, Bank of America, Wells Fargo & Co, Citigroup and Ally (formerly GMAC), and is intended to help homeowners having difficulty making their mortgage payments and individuals who were the victims of improper foreclosures.
According to Assistant Attorney General Holly Pomraning in a recent TheNorthwestern.com article, Wisconsin's share of the settlement will be divided and distributed as follows:
- ...
LAST 30 PRESS RELEASES:
California partnership aided COVID-19 response and health equity, report finds
University of Oklahoma secures $19.9 million for revolutionary radar technology
Study finds restoring order to dividing cancer cells may prevent metastasis
High-accuracy tumor detection with label-free microscopy and neural networks
Wayne State research reveals fetuses exposed to Zika virus have long-term immune challenges
Researchers deconstruct chikungunya outbreaks to improve prediction and vaccine development
Study finds one-year change on CT scans linked to future outcomes in fibrotic lung disease
Discovery of a novel intracellular trafficking pathway in plant cells
New tool helps forecast volcano slope collapses and tsunamis
Molecular coating cleans up noisy quantum light
From Parkinson's to rare diseases, discovered a key switch for cellular health
Tiny sugars in the brain disrupt emotional circuits, fueling depression
Mini-organs reveal how the cervix defends itself
Africa, climate, and food: How to feed a continent without increasing its carbon footprint
Researchers demonstrates substrate design principles for scalable superconducting quantum materials
How better software choices could cut US health care costs
Concussion history in NCAA athletes yields mixed health outcomes
Counting plastic reveals hidden waste and sparks action
Warming oceans may pose a serious threat to American lobsters
Deaths from drug-induced unintentional injury rise across the US
In car crashes with pedestrians, age and zip code may predict extent of traumatic injuries
AI optimizes evacuation, diagnosis, and treatment of wounded soldiers in Ukraine
Mastectomy linked to worsened sexual health, body image after surgery
Drop in credit score after cancer diagnosis linked to increased mortality, study shows
Use of weight loss drugs before bariatric surgery has soared in recent years, study finds
EMS call times in rural areas take at least 20 minutes longer than national average
Rectal bleeding in young adults linked to 8.5 times higher risk of colorectal cancer
Hospital closures disproportionately affect socioeconomically disadvantaged communities
Global disparities in premature mortality
Keck Medicine of USC expands world-class care in Pasadena
[Press-News.org] Study finds genes improving survival with higher chemo doses in leukemiaUniversity Hospitals Case Medical Center cancer researcher helps advance 'individualized' patient care with the find